A 1-Pot Synthesis of the SARS-CoV-2 M<sup>pro</sup> Inhibitor Nirmatrelvir, the Key Ingredient in Paxlovid.

Caravez, Juan C; Iyer, Karthik S; Kavthe, Rahul D; Kincaid, Joseph R A; Lipshutz, Bruce H

A 1-Pot Synthesis of the SARS-CoV-2 M^pro Inhibitor Nirmatrelvir, the Key Ingredient in Paxlovid.

Caravez, Juan C; Iyer, Karthik S; Kavthe, Rahul D; Kincaid, Joseph R A; Lipshutz, Bruce H.

Afiliación

Caravez JC; Department of Chemistry & Biochemistry, University of California, Santa Barbara, Santa Barbara, California 93106, United States.
Iyer KS; Department of Chemistry & Biochemistry, University of California, Santa Barbara, Santa Barbara, California 93106, United States.
Kavthe RD; Department of Chemistry & Biochemistry, University of California, Santa Barbara, Santa Barbara, California 93106, United States.
Kincaid JRA; Department of Chemistry & Biochemistry, University of California, Santa Barbara, Santa Barbara, California 93106, United States.
Lipshutz BH; Department of Chemistry & Biochemistry, University of California, Santa Barbara, Santa Barbara, California 93106, United States.

Org Lett ; 24(49): 9049-9053, 2022 12 16.

Article en En | MEDLINE | ID: mdl-36475781

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; Leucina; Antivirales/farmacología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Org Lett Asunto de la revista: BIOQUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google